Loading...
935106861
info@markelab.com
Precio
387.5€ (100 µg)
Cosibelimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD274, Cosibelimab is a fully-human monoclonal IgG1 antibody that blocks the interaction between PD-L1 and PD-1 and certain receptors called B7. 1 by binding to PD-L1.
Biosimilars
Human
Monoclonal
Human
CD274
Human
IgG1 Lambda
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 2216751-26-5
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más